{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:14:10Z","timestamp":1773695650496,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00415-023-12046-w","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T09:02:48Z","timestamp":1698915768000},"page":"1047-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neurosarcoidosis"],"prefix":"10.1007","volume":"271","author":[{"given":"Desmond P.","family":"Kidd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"12046_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/2040622318790197","volume":"9","author":"E Arkema","year":"2018","unstructured":"Arkema E, Cozier YC (2018) Epdemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic dis 9:227\u2013240","journal-title":"Ther Adv Chronic dis"},{"key":"12046_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","volume":"91","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Carmona EM, Utz JP, Ryu JH, Crowson CS, Matteson EL (2016) Epidemiology of sarcoidosis 1946\u20132013: a population-based study. Mayo Clin Proc 91:183\u2013188","journal-title":"Mayo Clin Proc"},{"key":"12046_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Field S, Costabel U et al (2016) Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc 13:1244\u20131252","journal-title":"Ann Am Thorac Soc"},{"key":"12046_CR4","first-page":"45","volume":"5","author":"J Grunewald","year":"2019","unstructured":"Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Muller-Quernheim J (2019) Sarcoidosis. Nat Rev 5:45","journal-title":"Nat Rev"},{"key":"12046_CR5","first-page":"233","volume":"85","author":"N Rajoriya","year":"2003","unstructured":"Rajoriya N, Wotton CJ, Yeates DGR et al (2003) Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. PMJ 85:233\u2013237","journal-title":"PMJ"},{"key":"12046_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cells10040766","volume":"10","author":"P Seve","year":"2021","unstructured":"Seve P, Pacheco Y, Durupt F et al (2021) Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells 10:766","journal-title":"Cells"},{"key":"12046_CR7","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885\u20131889","journal-title":"Am J Respir Crit Care Med"},{"key":"12046_CR8","first-page":"204","volume":"20","author":"MA Judson","year":"2003","unstructured":"Judson MA, Baughman RP, Thompson BW et al (2003) ACCESS Research Group. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 20:204\u2013211","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"12046_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/practneurol-2019-002349","volume":"20","author":"DP Kidd","year":"2020","unstructured":"Kidd DP (2020) Neurosarcoidosis: clinical manifestations, investigation and treatment. Pract Neurol 20:199\u2013212","journal-title":"Pract Neurol"},{"key":"12046_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MAO.0000000000000501","volume":"36","author":"M Carlson","year":"2015","unstructured":"Carlson M, White JR, Esahbodi M et al (2015) Cranial base manifestations of Neurosarcoidosis: a review of 305 patients. Otol Neurotol 36:156\u2013166","journal-title":"Otol Neurotol"},{"key":"12046_CR11","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1007\/s00415-018-8928-2","volume":"265","author":"DP Kidd","year":"2018","unstructured":"Kidd DP (2018) Sarcoidosis of the central nervous system: clinical features, imaging and CSF results. J Neurol 265:1906\u20131915","journal-title":"J Neurol"},{"key":"12046_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1212\/NXI.0000000000000270","volume":"3","author":"DP Kidd","year":"2016","unstructured":"Kidd DP, Burton BJ, Graham EM, Plant GT (2016) Optic neuropathy associated with systemic sarcoidosis. Neurol, Neuroimmunol Neuroinflamm 3:270","journal-title":"Neurol, Neuroimmunol Neuroinflamm"},{"key":"12046_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117282","volume":"420","author":"LM Webb","year":"2021","unstructured":"Webb LM, Chen JJ, Aksamit AJ et al (2021) A multi-center case series of sarcoid optic neuropathy. J Neurol Sci 420:117282","journal-title":"J Neurol Sci"},{"key":"12046_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","volume":"105","author":"C Langrand","year":"2012","unstructured":"Langrand C, Bihan H, Raverot G et al (2012) Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients. QJM 105:981\u2013995","journal-title":"QJM"},{"key":"12046_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11102-015-0678-x","volume":"19","author":"J Anthony","year":"2016","unstructured":"Anthony J, Esper GJ, Ioachimescu A (2016) Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review. Pituitary 19:19\u201329","journal-title":"Pituitary"},{"key":"12046_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105811","volume":"194","author":"DP Kidd","year":"2020","unstructured":"Kidd DP (2020) Sarcoidosis of the central nervous system: safety and efficacy of treatment, and experience of biological therapies. Clin Neurol Neurosurg 194:105811","journal-title":"Clin Neurol Neurosurg"},{"key":"12046_CR17","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00415-018-9001-x","volume":"265","author":"V Jachiet","year":"2018","unstructured":"Jachiet V, Lhote R, Rufat P et al (2018) Clinical, imaging and histological presentations and outcomes of stroke related to sarcoidosis. J Neurol 265:2333\u20132341","journal-title":"J Neurol"},{"key":"12046_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1161\/str.21.1.152b","volume":"21","author":"AM Corse","year":"1990","unstructured":"Corse AM, Stern BJ (1990) Neurosarcoidosis and stroke. Stroke 21:152\u2013153","journal-title":"Stroke"},{"key":"12046_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.12.003","volume":"21","author":"I Gonzalez-Aramuru","year":"2014","unstructured":"Gonzalez-Aramuru I, Ruiz-Perez E, Gomez-Roman J, Quince R, Larrosa D, Pascual J (2014) Sarcoidosis presenting as transient ischemic attack status. J Stroke Cerebrovasc Dis 21:515\u2013517","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"12046_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2176\/nmc.38.566","volume":"38","author":"K Takenaka","year":"1998","unstructured":"Takenaka K, Ito M, Kuamagai M et al (1998) Moyamoya disease associated with pulmonary sarcoidosis: case report. Neurol Med Chir (Tokyo) 38:566\u2013568","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"12046_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3340\/jkns.2009.45.1.50","volume":"45","author":"JK Ko","year":"2009","unstructured":"Ko JK, Lee SW, Choi CH (2009) Moyamoya-like vasculopathy in Neurosarcoidosis. J Korean Neurosurg Soc 45:50\u201352","journal-title":"J Korean Neurosurg Soc"},{"key":"12046_CR22","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1212\/NXI.0000000000001063","volume":"8","author":"G Bathla","year":"2021","unstructured":"Bathla G, Abdel-Wahed L, Agarwal A et al (2021) Vascular involevement in neurosarcoidosis: early experiences from intracranial vessel wall imaging. J Neurol Neuroimmunol Neuroinflamm 8:e1063","journal-title":"J Neurol Neuroimmunol Neuroinflamm"},{"key":"12046_CR23","volume":"68","author":"S Hutto","year":"2022","unstructured":"Hutto S, Kyle K, Balaban DT, Martinez Lage M, Venna N (2022) Ischemic sroke in neurosarcoidosis: a retrospective cohort analysis. Mult Scler 68:104227","journal-title":"Mult Scler"},{"key":"12046_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1468-1331.2012.03783.x","volume":"20","author":"JP O\u2019Dwyer","year":"2013","unstructured":"O\u2019Dwyer JP, Al-Moyeed BA, Farrell MA et al (2013) Neurosarcoidosis-related intracranial haemorrhage: three new cases and a systematic review of the literature. Eur J Neurol 20:71\u201378","journal-title":"Eur J Neurol"},{"key":"12046_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MD.0b013e3181d5c6b4","volume":"89","author":"F Cohen-Aubart","year":"2010","unstructured":"Cohen-Aubart F, Galanaud D, Grabli D et al (2010) Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine (Baltimore) 89:133\u2013140","journal-title":"Medicine (Baltimore)"},{"key":"12046_CR26","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00415-011-6080-3","volume":"258","author":"K Sakushima","year":"2011","unstructured":"Sakushima K, Yabe I, Nakano F et al (2011) Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients. J Neurol 258:2163\u20132167","journal-title":"J Neurol"},{"key":"12046_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MAJ.0b013e3182808781","volume":"347","author":"M Sohn","year":"2014","unstructured":"Sohn M, Culver DA, Judson MA, Scott TF, Tavee J, Nozaki K (2014) Spinal cord neurosarcoidosis. Am J Med Sci 347:195\u2013198","journal-title":"Am J Med Sci"},{"key":"12046_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00415-016-8092-5","volume":"263","author":"CA Durel","year":"2016","unstructured":"Durel CA, Marignier R, Maucort-Boulch D et al (2016) Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients. J Neurol 263:981\u2013990","journal-title":"J Neurol"},{"key":"12046_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/01.nrl.0000159983.19068.21","volume":"11","author":"K Kaiboriboon","year":"2005","unstructured":"Kaiboriboon K, Olsen TJ, Hayat GR (2005) Cauda equina and conus medullaris syndrome in sarcoidosis. Neurologist 11:179\u2013183","journal-title":"Neurologist"},{"key":"12046_CR30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.clineuro.2007.06.003","volume":"109","author":"S Miura","year":"2007","unstructured":"Miura S, Kusumoto M, Noda K et al (2007) Bell-shaped sensory impairments of all modalities in a neurosarcoidosis patient. Clin Neurol Neurosurg 109:794\u2013798","journal-title":"Clin Neurol Neurosurg"},{"key":"12046_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jns.2009.03.005","volume":"281","author":"A Uzawa","year":"2009","unstructured":"Uzawa A, Kojima S, Yonezu T, Kanesaka T (2009) Truncal polyradiculopathy due to sarcoidosis. J Neurol Sci 281:108\u2013109","journal-title":"J Neurol Sci"},{"key":"12046_CR32","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1212\/WNL.41.10.1558","volume":"41","author":"G Zuniga","year":"1991","unstructured":"Zuniga G, Ropper AH, Frank J (1991) Sarcoid peripheral neuropathy. Neurology 41:1558\u20131561","journal-title":"Neurology"},{"key":"12046_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jns.2006.01.014","volume":"244","author":"TM Burns","year":"2006","unstructured":"Burns TM, Dyck PJ, Aksamit AJ, Dyck PJ (2006) The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases. J Neurol Sci 244:77\u201387","journal-title":"J Neurol Sci"},{"key":"12046_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/B978-0-444-52902-2.00027-8","volume":"115","author":"G Said","year":"2013","unstructured":"Said G (2013) Sarcoidosis of the peripheral nervous system. Handb Clin Neurol 115:485\u2013495","journal-title":"Handb Clin Neurol"},{"key":"12046_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577864","volume":"368","author":"J Tavee","year":"2022","unstructured":"Tavee J (2022) Peripheral neuropathy in sarcoidosis. J Neuroimmunol 368:577864","journal-title":"J Neuroimmunol"},{"key":"12046_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2169\/internalmedicine.49.2894","volume":"49","author":"S Sawai","year":"2010","unstructured":"Sawai S, Misawa S, Kobayashi M et al (2010) Multifocal conduction blocks in sarcoid peripheral neuropathy. Intern Med 49:471\u2013474","journal-title":"Intern Med"},{"key":"12046_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.410070213","volume":"7","author":"SJ Oh","year":"1980","unstructured":"Oh SJ (1980) Sarcoid polyneuropathy: a histologically proved case. Ann Neurol 7:178\u2013181","journal-title":"Ann Neurol"},{"key":"12046_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/brain\/awf027","volume":"125","author":"G Said","year":"2002","unstructured":"Said G, Lacroix C, Plant\u00e9-Bordeneuve V et al (2002) Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 125:264\u2013675","journal-title":"Brain"},{"key":"12046_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5414\/NPP27096","volume":"27","author":"A Vital","year":"2008","unstructured":"Vital A, Lagueny A, Ferrer X, Louiset P, Canron MH, Vital C (2008) Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature. Clin Neuropathol 27:96\u2013105","journal-title":"Clin Neuropathol"},{"key":"12046_CR40","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","volume":"359","author":"E Hoitsma","year":"2002","unstructured":"Hoitsma E, Marziniak M, Faber CC et al (2002) Small fibre neuropathy in sarcoidosis. Lancet 359:2085\u20132086","journal-title":"Lancet"},{"key":"12046_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","volume":"26","author":"JO Tavee","year":"2017","unstructured":"Tavee JO, Karwa K, Ahmed Z, Thompson N, Parambil J, Culver DA (2017) Sarcoidosis-associated small fibre neuropathy in a large cohort: clinical aspects and response to IVIg and anti-TNF alpha treatment. Respir Med 26:135\u2013213","journal-title":"Respir Med"},{"key":"12046_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577975","volume":"373","author":"M Garret","year":"2022","unstructured":"Garret M, Pestronk A (2022) Sarcoidosis, granulomas and myopathy syndromes: a clinic-pathological review. J Neuroimmunol 373:577975","journal-title":"J Neuroimmunol"},{"key":"12046_CR43","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000452","volume":"16","author":"F Cohen Aubart","year":"2018","unstructured":"Cohen Aubart F, Abbara S, Maisonobe T et al (2018) Symptomatic muscular sarcoidosis: lessons from a nationawide multicentre study. Neurol Neuroimmunol Neuroinflamm 16:e452","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12046_CR44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.nmd.2022.05.012","volume":"32","author":"L Ten Dam","year":"2022","unstructured":"Ten Dam L, Raaphorst J, van der Kooi AJ et al (2022) Clinical characteristics and outcome in muscular sarcoidosis: a retrospective cohort study and literature review. Neuromuscul Disord 32:557\u2013563","journal-title":"Neuromuscul Disord"},{"key":"12046_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jns.2013.09.008","volume":"335","author":"O Wengert","year":"2013","unstructured":"Wengert O, Rothenfusser-Korber E, Vollrath B et al (2013) Neurosarcoidosis: correlation of cerebrospinal fluid findings wit diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity. J Neurol Sci 335:124\u2013130","journal-title":"J Neurol Sci"},{"key":"12046_CR46","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/ene.13975","volume":"26","author":"T Chazal","year":"2019","unstructured":"Chazal T, Christopoulos M, Maillert E et al (2019) The cerebrospinal fluid CD4\/CD8 ratio and interleukin-6 and -10 levels in Neurosarcoidosis: a multicentre, pragmatic, comparative study. Eur J Neurol 26:1274\u20131280","journal-title":"Eur J Neurol"},{"key":"12046_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577860","volume":"367","author":"MA Paley","year":"2022","unstructured":"Paley MA, Baker BJ, Dunham SR et al (2022) The CSF in neurosarcoidosis contains consistent cloncal expansion of CD8 T cells, but not CD4 T cells. J Neuroimmunol 367:577860","journal-title":"J Neuroimmunol"},{"key":"12046_CR48","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000725","volume":"11","author":"C Otto","year":"2020","unstructured":"Otto C, Wengert O, Unterwalder N, Meisel C, Ruprecht K (2020) Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis. Neurol Neuroimmunol Neuroinflamm 11:e725","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12046_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577849","volume":"367","author":"KE Byg","year":"2022","unstructured":"Byg KE, Illes Z, Sejbaek T, Lambertsen KL, Ellingsen T, Nielsen HH (2022) Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis. J Neuroimmunol 367:577849","journal-title":"J Neuroimmunol"},{"key":"12046_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/qjmed\/hcz148","volume":"112","author":"E Riviere","year":"2019","unstructured":"Riviere E, Schwartz P, Machelart I et al (2019) Neurosarcoidosis and infliximab therapy monitored by 18-FDG PET\/CT. QJM 112:695\u2013697","journal-title":"QJM"},{"key":"12046_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clineuro.2012.03.042","volume":"115","author":"S Bartels","year":"2013","unstructured":"Bartels S, Kyavar L, Blumstein N et al (2013) FDG PET findings leading to the diagnosis of neurosarcoidosis. Clin Neurol Neurosurgery 115:85\u201388","journal-title":"Clin Neurol Neurosurgery"},{"key":"12046_CR52","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/ijnm.IJNM_82_19","volume":"34","author":"N Seniaray","year":"2019","unstructured":"Seniaray N, Jain A (2019) 18-F fluorodeoxyglucose positron emission tomography \u2013 computed tomography \/ magnetic resonance imaging in neurosarcoidosis. Indian J Nucl Med 34:344\u2013346","journal-title":"Indian J Nucl Med"},{"key":"12046_CR53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.semnuclmed.2022.08.004","volume":"53","author":"C Regis","year":"2023","unstructured":"Regis C, Benali K, Rouzet F (2023) FDG PET\/CT imaging of sarcoidosis. Semin Nucl Med 53:258\u2013272","journal-title":"Semin Nucl Med"},{"key":"12046_CR54","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.mayocp.2020.01.032","volume":"95","author":"D Fritz","year":"2020","unstructured":"Fritz D, van den Beek D, Brouwer MC, Booij J (2020) Whole body 18F-FDG PET-CT in the diagnosis of neurosarcoidosis. Mayo Clin Proc 95:1082\u20131084","journal-title":"Mayo Clin Proc"},{"key":"12046_CR55","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1212\/WNL.0b013e3182684672","volume":"79","author":"JF Huang","year":"2012","unstructured":"Huang JF, Aksemit AJ, Staff N (2012) MRI and PET imaging discordance in Neurosarcoidosis. Neurology 79:1070","journal-title":"Neurology"},{"key":"12046_CR56","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M et al (2014) The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarc Vasc Diffuse Lung Dis 31:19\u201327","journal-title":"Sarc Vasc Diffuse Lung Dis"},{"key":"12046_CR57","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","volume":"75","author":"BJ Stern","year":"2018","unstructured":"Stern BJ, Royal W, Gelfand JM et al (2018) Definition and consensus diagnostic criteria for Neurosarcoidosis from the Neurosarcoidosis consortium consensus group. JAMA Neurol 75:1546\u20131553","journal-title":"JAMA Neurol"},{"key":"12046_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12016-015-8492-9","volume":"49","author":"RP Baughman","year":"2015","unstructured":"Baughman RP, Lower EE (2015) Treatment of Sarcoidosis. Clin Rev Allergy Immunol 49:79\u201392","journal-title":"Clin Rev Allergy Immunol"},{"key":"12046_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0000000000003431","volume":"87","author":"S Bitoun","year":"2016","unstructured":"Bitoun S, Bouvry D, Borie R et al (2016) Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil. Neurology 87:1\u20135","journal-title":"Neurology"},{"key":"12046_CR60","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1001\/jamaneurol.2017.2492","volume":"74","author":"B Joubert","year":"2017","unstructured":"Joubert B, Chapelon-Abric C, Biard L et al (2017) Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis. JAMA Neurol 74:1336\u20131344","journal-title":"JAMA Neurol"},{"key":"12046_CR61","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/1744666X.2016.1175301","volume":"12","author":"LA Saketkoo","year":"2016","unstructured":"Saketkoo LA, Baughman RP (2016) Biologic therapies in the treatment of sarcoidosis. Expert Rev Clin Immunol 12:817\u2013825","journal-title":"Expert Rev Clin Immunol"},{"key":"12046_CR62","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","volume":"47","author":"Y Jamilloux","year":"2018","unstructured":"Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C et al (2018) Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicentre study of 132 patients. Semin Arth Rheum 47:288\u2013294","journal-title":"Semin Arth Rheum"},{"key":"12046_CR63","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00415-017-8444-9","volume":"264","author":"F Cohen-Aubart","year":"2017","unstructured":"Cohen-Aubart F, Bouvry D, Galanaud D et al (2017) Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol 264:891\u2013897","journal-title":"J Neurol"},{"key":"12046_CR64","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","volume":"89","author":"JM Gelfand","year":"2017","unstructured":"Gelfand JM, Bradshaw MJ, Stern BJ et al (2017) Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series. Neurology 89:2092\u20132100","journal-title":"Neurology"},{"key":"12046_CR65","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1212\/WNL.0000000000009526","volume":"94","author":"DP Kidd","year":"2020","unstructured":"Kidd DP, Galloway M, Wilhelm T (2020) Relapse of severe neurosarcoidosis with switch from originator infliximab to biosimilar. Neurology 94:991\u2013993","journal-title":"Neurology"},{"key":"12046_CR66","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00415-019-09234-y","volume":"266","author":"Q Riller","year":"2019","unstructured":"Riller Q, Cotteret C, Junot H et al (2019) Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment. J Neurol 266:1073\u20131078","journal-title":"J Neurol"},{"key":"12046_CR67","volume":"1","author":"M Sharp","year":"2019","unstructured":"Sharp M, Donnelly SC, Moller DR (2019) Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents. Respir Med J 1:100004","journal-title":"Respir Med J"},{"key":"12046_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418805732","volume":"11","author":"S Zella","year":"2018","unstructured":"Zella S, Kneiphof J, Haghikia A, Gold R, Woitalla, Thone J (2018) Successful therapy with rituximab in three patients with probable neurosarcoidosis. Ther Adv Neurol Disord 11:1756286418805732","journal-title":"Ther Adv Neurol Disord"},{"key":"12046_CR69","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1183\/09031936.00000914","volume":"44","author":"MA Judson","year":"2014","unstructured":"Judson MA, Baughman RP, Costabel U et al (2014) Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur Respir J 44:1296\u20131307","journal-title":"Eur Respir J"},{"key":"12046_CR70","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1038\/s41598-017-04109-6","volume":"26","author":"T Zhou","year":"2017","unstructured":"Zhou T, Casanova N, Pouladi N et al (2017) Identification of Jak-STAT signalling involvement in sarcoidosis severity via a novel micro-RNA-regulated peripheral blood mononuclear cell gene signature. Sci Rep 26:4237","journal-title":"Sci Rep"},{"key":"12046_CR71","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","volume":"379","author":"W Damsky","year":"2018","unstructured":"Damsky W, Thakral D, Emeagwali N, Galan A, King B (2018) Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis. N Engl J Med 379:2540\u20132546","journal-title":"N Engl J Med"},{"key":"12046_CR72","first-page":"73","volume":"23","author":"E Hoitsma","year":"2006","unstructured":"Hoitsma E, Faber CG, van Santen-Hoeufft M, de Vries J, Reulen JP, Drent M (2006) Improvement of small fibre neuropathy in a sarcoidosis patient after treatment with infliximab. Sarc Vasc Diff Lung Dis 23:73\u201377","journal-title":"Sarc Vasc Diff Lung Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12046-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12046-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12046-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T03:03:52Z","timestamp":1706670232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12046-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["12046"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12046-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"12 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Kidd reports no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}